Early knowledge of AKI risk may prompt closer patient monitoring and help prevent permanent kidney damage or death Ortho-Clinical Diagnostics, Inc. today announced the nationwide availability to ...
Analysts are estimating that Co-Diagnostics will report an earnings per share (EPS) of $-0.19. Anticipation surrounds ...
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the launch and availability of the ...
Company focused on advancing clinical milestones and strategic partnerships, with goal of positioning itself for future FDA clearance and product commercialization.Patient enrollment in SYMON-II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback